CureVac won't seek U.S. approval for first-generation Covid vaccine By: Boston Business Journal via Business Journals August 16, 2021 at 13:06 PM EDT The German-headquartered biotech, whose U.S. office is in Boston, will focus instead on European authorization for its Covid-19 vaccine. Read More >>